MOUNTAIN VIEW, Calif., Jan. 09, 2025 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a biotechnology company committed to developing and delivering medicines to treat patients with ...

MOUNTAIN VIEW, Calif., Jan. 09, 2025 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a biotechnology company committed to developing and delivering medicines to treat patients with ...

IGM Biosciences is laying off almost three-fourths of its staff after a crucial clinical study delivered poor results. The Mountain View company, whose current research focuses on autoimmune ...

IGM Biosciences Background Information (This description is provided by the company.) Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused ...

The company was founded in 2010 and is headquartered in Mountain View, CA. Read More on IGMS: IGM Biosciences NewsMORE Related Stocks Indices ...

IGM Biosciences Inc. (Nasdaq: IGMS) of Mountain View said Thursday that it plans to cut roughly 160 of its 220-person workforce and stop development of two drugs. Meanwhile, privately held Scribe ...

Fresh layoffs have jolted the Bay Area, staffing reductions that are poised to eliminate about 600 jobs in the region.

IGM Biosciences is cutting 73% of its workforce and stopping development of two autoimmune drug candidates, the biotech announced Jan. 9. Following the news, BMO Capital Markets downgraded the ...

IGM Financial, a major Canadian wealth management firm, faces many of the same challenges as peer firms - notably market ...

Jefferies downgraded IGM Biosciences (IGMS ... the firm removed clinical program revenue from its model and lowered its view of platform value to $50M, mostly related to the still-ongoing Sanofi ...